2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… Mehr…
booklooker.de buecher.de GmbH & Co. KG Versandkosten:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - gebunden oder broschiert
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Mehr…
booklooker.de |
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - gebunden oder broschiert
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Mehr…
booklooker.de |
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - gebunden oder broschiert
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Mehr…
booklooker.de |
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… Mehr…
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Versandkosten:Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… Mehr…
Prugnaud, Jean-Louis:
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - gebunden oder broschiert2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Mehr…
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - gebunden oder broschiert
2012
ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Mehr…
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - gebunden oder broschiert
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … Mehr…
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… Mehr…
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities.
In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature.
This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the Eu
Detailangaben zum Buch - Biosimilars
EAN (ISBN-13): 9782817803357
ISBN (ISBN-10): 2817803353
Gebundene Ausgabe
Erscheinungsjahr: 20121130
Herausgeber: Springer Editions
87 Seiten
Gewicht: 0,343 kg
Sprache: Englisch
Buch in der Datenbank seit 2007-02-10T18:10:29+01:00 (Zurich)
Detailseite zuletzt geändert am 2022-08-19T11:29:49+02:00 (Zurich)
ISBN/EAN: 9782817803357
ISBN - alternative Schreibweisen:
2-8178-0335-3, 978-2-8178-0335-7
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: jean hugues, john seymour, louis
Titel des Buches: leben auf dem lande
Daten vom Verlag:
Autor/in: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Titel: Biosimilars - A New Generation of Biologics
Verlag: Springer; Springer Paris
90 Seiten
Erscheinungsjahr: 2012-11-21
Paris; FR
Gedruckt / Hergestellt in Niederlande.
Gewicht: 0,336 kg
Sprache: Englisch
128,39 € (DE)
131,99 € (AT)
142,00 CHF (CH)
POD
XVIII, 90 p.
BB; Oncology; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BC; EA
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< zum Archiv...